Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq
Nature's Miracle Holding (NASDAQ: NMHI), a vertical farming technology company, announced receiving a delisting notification from Nasdaq on January 13, 2025. The delisting is due to the company's failure to meet the minimum shareholder's equity requirement under Nasdaq Listing Rule 5550(b)(1).
Trading of NMHI's common stock and warrants will be suspended on Nasdaq effective January 15, 2025. The company has 15 days to appeal the decision to the Nasdaq Listing and Hearing Review Council, which can also independently review the decision within 45 calendar days.
Following the Nasdaq suspension, NMHI's common stock and warrants are expected to be quoted on the OTC Pink market under the symbols 'NMHI' and 'NMHW' respectively.
Nature's Miracle Holding (NASDAQ: NMHI), un'azienda di tecnologia per l'agricoltura verticale, ha annunciato di aver ricevuto una notifica di esclusione dalla Nasdaq il 13 gennaio 2025. L'esclusione 猫 dovuta al mancato rispetto da parte dell'azienda del requisito minimo di patrimonio netto degli azionisti ai sensi della Regola di Quotazione 5550(b)(1) di Nasdaq.
Le contrattazioni delle azioni ordinarie di NMHI e dei warrant saranno sospese su Nasdaq a partire dal 15 gennaio 2025. L'azienda ha 15 giorni per presentare ricorso al Nasdaq Listing and Hearing Review Council, che pu貌 anche riesaminare indipendentemente la decisione entro 45 giorni di calendario.
Dopo la sospensione da parte di Nasdaq, si prevede che le azioni ordinarie di NMHI e i warrant vengano quotati sul mercato OTC Pink con i simboli 'NMHI' e 'NMHW' rispettivamente.
Nature's Miracle Holding (NASDAQ: NMHI), una empresa de tecnolog铆a de agricultura vertical, anunci贸 haber recibido una notificaci贸n de exclusi贸n de Nasdaq el 13 de enero de 2025. La exclusi贸n se debe al incumplimiento de la empresa del requisito m铆nimo de capital de los accionistas seg煤n la Regla de Cotizaci贸n 5550(b)(1) de Nasdaq.
La negociaci贸n de las acciones ordinarias de NMHI y los warrants se suspender谩 en Nasdaq a partir del 15 de enero de 2025. La empresa tiene 15 d铆as para apelar la decisi贸n ante el Nasdaq Listing and Hearing Review Council, que tambi茅n puede revisar la decisi贸n de manera independiente dentro de los 45 d铆as naturales siguientes.
Tras la suspensi贸n de Nasdaq, se espera que las acciones ordinarias de NMHI y los warrants sean cotizados en el mercado OTC Pink bajo los s铆mbolos 'NMHI' y 'NMHW' respectivamente.
Nature's Miracle Holding (NASDAQ: NMHI), 靾橃 雴嶌梾 旮办垹 須岇偓臧� 2025雲� 1鞗� 13鞚� 雮橃姢雼レ溂搿滊秬韯� 靸侅灔 韽愳 韱惦炒毳� 氚涭晿雼り碃 氚滍憸頄堨姷雼堧嫟. 靸侅灔 韽愳電� 雮橃姢雼� 靸侅灔 攴滌箼 5550(b)(1)鞐� 霐半ジ 斓滌唽 欤检＜ 鞛愲掣 鞖旉贝鞚� 於╈”頃橃 氇豁枅旮� 霑岆鞛呺媹雼�.
NMHI鞚� 氤错喌欤检檧 鞗岆煱韸胳潣 瓯半灅電� 2025雲� 1鞗� 15鞚茧秬韯� 雮橃姢雼レ棎靹� 欷戨嫧霅╇媹雼�. 鞚� 須岇偓電� 雮橃姢雼� 靸侅灔 氚� 觳須� 瓴�韱� 鞙勳洂須岇棎 瓴办爼鞐� 頃唽頃� 靾� 鞛堧姅 15鞚检澊 鞛堨溂氅�, 鞙勳洂須岆姅 45鞚� 鞚措偞鞐� 瓴办爼鞐� 雽�頃� 霃呺鞝侅澑 瓴�韱犽ゼ 歆勴枆頃� 靾橂弰 鞛堨姷雼堧嫟.
雮橃姢雼レ潣 瓯半灅 欷戨嫧 鞚错泟, NMHI鞚� 氤错喌欤检檧 鞗岆煱韸鸽姅 臧侁皝 'NMHI' 氚� 'NMHW' 旮绊樃搿� OTC Pink 鞁滌灔鞐� 靸侅灔霅� 鞓堨爼鞛呺媹雼�.
Nature's Miracle Holding (NASDAQ: NMHI), une entreprise de technologie de culture verticale, a annonc茅 avoir re莽u une notification de radiation de la Nasdaq le 13 janvier 2025. La radiation est due 脿 l'incapacit茅 de l'entreprise 脿 r茅pondre 脿 l'exigence minimale de capitaux propres des actionnaires conform茅ment 脿 la r猫gle de cotation 5550(b)(1) de la Nasdaq.
La n茅gociation des actions ordinaires de NMHI et des bons de souscription sera suspendue sur la Nasdaq 脿 compter du 15 janvier 2025. L'entreprise a 15 jours pour faire appel de la d茅cision aupr猫s du Nasdaq Listing and Hearing Review Council, qui peut 茅galement revoir ind茅pendamment la d茅cision dans les 45 jours suivant le calendrier.
Suite 脿 la suspension par la Nasdaq, les actions ordinaires de NMHI et les bons de souscription devraient 锚tre cot茅s sur le march茅 OTC Pink sous les symboles 'NMHI' et 'NMHW' respectivement.
Nature's Miracle Holding (NASDAQ: NMHI), ein Unternehmen f眉r vertikale Landwirtschaftstechnologie, gab bekannt, am 13. Januar 2025 eine Abberufungsbenachrichtigung von der Nasdaq erhalten zu haben. Die Abberufung erfolgt aufgrund der Nichteinhaltung der Mindestanforderungen an das Eigenkapital der Aktion盲re gem盲脽 der Nasdaq-Listing-Regel 5550(b)(1).
Der Handel mit den Stammaktien von NMHI und den Warrants wird ab dem 15. Januar 2025 an der Nasdaq ausgesetzt. Das Unternehmen hat 15 Tage Zeit, um gegen die Entscheidung beim Nasdaq-Listing- und Hearing-Review-Rat Berufung einzulegen, der die Entscheidung auch innerhalb von 45 Kalendertagen unabh盲ngig 眉berpr眉fen kann.
Nach der Aussetzung durch die Nasdaq wird erwartet, dass die Stammaktien von NMHI und die Warrants unter den Symbolen 'NMHI' und 'NMHW' jeweils im OTC Pink Markt notiert werden.
- None.
- Delisting from Nasdaq due to non-compliance with minimum shareholder's equity requirement
- Downgrade to OTC Pink market trading, potentially reducing stock visibility and liquidity
- Loss of Nasdaq listing status may impact investor confidence and access to capital markets
Insights
The delisting notification represents a severe blow to Nature's Miracle's market position and investor accessibility. Moving from Nasdaq to OTC Pink marks a significant downgrade in trading venue, which typically results in reduced liquidity, decreased institutional investor interest and more challenging capital raising conditions. The failure to maintain the minimum shareholder's equity requirement suggests serious underlying financial health issues.
The transition to OTC Pink trading usually leads to:
- Reduced trading volume and wider bid-ask spreads
- access to institutional capital
- Decreased analyst coverage
- Higher cost of capital for future fundraising
While the company has appeal options, historical patterns show that successful appeals in cases of equity requirement violations are rare unless accompanied by substantial capital infusion or strategic restructuring. The
The delisting process reveals critical regulatory compliance failures that extend beyond mere technical violations. The company's inability to maintain minimum shareholder's equity under Rule 5550(b)(1) indicates fundamental governance concerns. While the 15-day appeal window provides a temporary lifeline, the transition to OTC Pink trading appears increasingly likely.
Key legal implications include:
- Increased vulnerability to shareholder litigation
- Enhanced reporting burdens to maintain market confidence
- Potential breach of existing financial covenants
The company's statement about 'considering' an appeal, rather than definitively pursuing one, suggests confidence in meeting compliance requirements. This regulatory setback could trigger cascading effects on existing contracts and financing agreements that may contain Nasdaq listing requirements as covenants.
The Company has 15 days after the date it received notice of the Panel's decision to request that the Nasdaq Listing and Hearing Review Council (the "Council") review the Hearing Panel's decision, or the Council may, on its own motion, determine to review the Hearing Panel's decision within 45 calendar days of the issuance of 听the decision.
The Company is considering to appeal the decision.
Upon suspension of the trading of its common stock on Nasdaq, the Company expects that its common stock and warrants will be quoted under its existing symbol "NMHI" and "NMHW" respectively, on the OTC Pink .
About Nature's Miracle Holding Inc.
Nature's Miracle () is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture ("CEA") industry around the world. The company has recently launched EV and听bitcoin听business, all energy dependent as CEA.听听
Forward-Looking Statements
The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature's Miracle's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature's Miracle's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature's Miracle's ability to develop and launch new products and services; Nature's Miracle's ability to successfully and efficiently integrate future expansion plans and opportunities; Nature's Miracle's ability to grow its business in a cost-effective manner; Nature's Miracle's product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature's Miracle's business model; developments and projections relating to Nature's Miracle's competitors and industry; and Nature's Miracle's approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on Nasdaq; changes in applicable laws or regulations; the effects of the coronavirus (COVID-19) and any future outbreaks on Nature's Miracle's business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature's Miracle's operates; the risk that Nature's Miracle's and its current and future collaborators are unable to successfully develop and commercialize Nature's Miracle's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature's Miracle's is unable to secure or protect its intellectual property; the possibility that Nature's Miracle's may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature's Miracle's filings from time to time with the SEC.
For more information, please contact:
Nature's Miracle Holding, Inc.
Investor Relations Department
ir@nature-miracle.com听
Ascent Investors Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email:听investors@ascent-ir.com
View original content:
SOURCE Nature's Miracle Holding Inc.
FAQ
Why is Nature's Miracle (NMHI) being delisted from Nasdaq?
When will NMHI stock be suspended from trading on Nasdaq?
What happens to NMHI shares after Nasdaq delisting?
Can Nature's Miracle appeal the Nasdaq delisting decision?
